• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing

    5/15/24 9:18:11 AM ET
    $AME
    $HTZ
    $MNMD
    $MOD
    Industrial Machinery/Components
    Industrials
    Rental/Leasing Companies
    Consumer Discretionary
    Get the next $AME alert in real time by email

    On CNBC's “Mad Money Lightning Round,” Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA).

    On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and announced a price target of $120.

    The “Mad Money” host likes Mind Medicine (MindMed) Inc. (NASDAQ:MNMD). “Anything that makes it so that there's ways to be able to get rid of pain and do good without getting people hooked, I am all in on. Doesn't necessarily mean it will make a lot of money, I don't care,” he added.

    On May 13, Oppenheimer analyst Francois Brisebois reiterated Mind Medicine with an Outperform and lowered the price target from $29 to $20.

    “I don't want you to sell, and I don't want you to double down,” Cramer said when asked about Hertz Global Holdings, Inc. (NASDAQ:HTZ). “Let's just see if it can't go higher.”

    On April 25, Hertz Global reported mixed first-quarter financial results.

    Cramer recommended buying Modine Manufacturing Company (NYSE:MOD). “That kind of metal-bending industrial company is precisely what's working here,” he added.

    Modine is scheduled to host a conference call and webcast to discuss its fourth quarter and fiscal year 2024 financial results on Wednesday, May 22.

    AMETEK, Inc. (NYSE:AME) is a buy, Cramer said. It is an “absolutely terrific” company.

    On May 2, AMETEK reported worse-than-expected first-quarter sales results.

    When asked about Palantir Technologies Inc. (NYSE:PLTR), he said, “The quarters are uneven.”

    On May 6, Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million, according to Benzinga Pro.

    Price Action:

    • Moderna shares rose 2.1% to settle at $128.32 on Tuesday.
    • MindMed shares rose 0.5% to close at $8.49.
    • Modine Manufacturing shares rose 4.4% to settle at $105.66 on Tuesday.
    • AMETEK shares fell 0.9% to settle at $168.53.
    • Hertz shares rose 9.7% to close at $6.00 on Tuesday.
    • Palantir shares rose 2.4% to settle at $21.44 on Tuesday.

    Read Next: Cisco, Prestige Consumer Healthcare And 3 Stocks To Watch Heading Into Wednesday

    Image: Shutterstock

    Get the next $AME alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AME
    $HTZ
    $MNMD
    $MOD

    CompanyDatePrice TargetRatingAnalyst
    Palantir Technologies Inc.
    $PLTR
    2/27/2026$150.00Buy
    Rosenblatt
    Palantir Technologies Inc.
    $PLTR
    2/27/2026$150.00Neutral → Buy
    UBS
    Modine Manufacturing Company
    $MOD
    2/18/2026$263.00Buy
    Roth Capital
    Palantir Technologies Inc.
    $PLTR
    2/18/2026$195.00Neutral → Outperform
    Mizuho
    Palantir Technologies Inc.
    $PLTR
    2/10/2026$180.00Neutral → Buy
    Daiwa Securities
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$205.00Hold → Buy
    HSBC Securities
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$190.00Market Perform → Outperform
    Northland Capital
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$200.00Neutral → Outperform
    Robert W. Baird
    More analyst ratings

    $AME
    $HTZ
    $MNMD
    $MOD
    SEC Filings

    View All

    SEC Form DEF 14A filed by Moderna Inc.

    DEF 14A - Moderna, Inc. (0001682852) (Filer)

    3/16/26 4:31:50 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEFA14A filed by Moderna Inc.

    DEFA14A - Moderna, Inc. (0001682852) (Filer)

    3/16/26 4:32:27 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEFA14A filed by AMETEK Inc.

    DEFA14A - AMETEK INC/ (0001037868) (Filer)

    3/11/26 9:08:44 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HTZ
    $MNMD
    $MOD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Planishek Heather A. bought $1,161,400 worth of shares (10,000 units at $116.14), increasing direct ownership by 21% to 58,006 units (SEC Form 4)

    4 - Palantir Technologies Inc. (0001321655) (Issuer)

    5/12/25 7:57:39 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Director Wulfsohn William A bought $200,958 worth of shares (2,530 units at $79.43), increasing direct ownership by 53% to 7,277 units (SEC Form 4)

    4 - MODINE MANUFACTURING CO (0000067347) (Issuer)

    3/5/25 9:25:30 AM ET
    $MOD
    Auto Parts:O.E.M.
    Consumer Discretionary

    Chief Executive Officer Bancel Stephane bought $5,004,318 worth of shares (160,314 units at $31.22) (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    3/4/25 4:27:16 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AME
    $HTZ
    $MNMD
    $MOD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AME
    $HTZ
    $MNMD
    $MOD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Speranza Emanuela

    4 - AMETEK INC/ (0001037868) (Issuer)

    3/23/26 4:07:01 PM ET
    $AME
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Zapico David A

    4 - AMETEK INC/ (0001037868) (Issuer)

    3/23/26 9:03:23 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Ciampitti Tony J

    4 - AMETEK INC/ (0001037868) (Issuer)

    3/23/26 8:55:43 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HTZ
    $MNMD
    $MOD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rosenblatt initiated coverage on Palantir Technologies with a new price target

    Rosenblatt initiated coverage of Palantir Technologies with a rating of Buy and set a new price target of $150.00

    2/27/26 8:31:30 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Palantir Technologies upgraded by UBS with a new price target

    UBS upgraded Palantir Technologies from Neutral to Buy and set a new price target of $150.00

    2/27/26 8:22:27 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Roth Capital initiated coverage on Modine Manufacturing with a new price target

    Roth Capital initiated coverage of Modine Manufacturing with a rating of Buy and set a new price target of $263.00

    2/18/26 7:54:26 AM ET
    $MOD
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AME
    $HTZ
    $MNMD
    $MOD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    A Defense-Grade AI Company Just Secured an Exclusive Pathway to Two Offshore Energy Blocks in West Africa. Here's Why That Matters

    VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com — The most valuable technology companies of the next decade will not be the ones that stay in their lane. They will be the ones that take defense-grade capabilities — AI, autonomy, sensing, signal processing — and deploy them into the trillion-dollar industries where legacy methods still dominate.That thesis is playing out in real time across the defence-industrial complex. Palantir Technologies (NYSE:PLTR) just had 75 separate U.S. Army contracts consolidated into a single $10 billion enterprise agreement, reflecting the military's shift from buying individual tools to licensing entire AI-driven platforms.

    3/24/26 11:00:00 AM ET
    $KTOS
    $OII
    $PLTR
    Military/Government/Technical
    Industrials
    Oilfield Services/Equipment
    Energy

    Palantir and Moder Partner to Transform Mortgage Industry

    Moder and Palantir are co-building an AI-powered mortgage operations platform, with first pilot customer Freedom Mortgage, a new milestone toward empowering the dream of homeownership Palantir Technologies Inc. (NASDAQ:PLTR), a global leader in operational artificial intelligence platforms, and Moder, the fastest growing AI and technology outsourcing company in mortgage, today announced a strategic partnership to co-build an AI-powered mortgage operations platform with first pilot customer Freedom Mortgage, bringing Palantir's capabilities around data and AI to the forefront of the mortgage industry alongside Moder's domain expertise. The co-built platform leverages Palantir's Ontology

    3/19/26 6:59:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Hertz Expands Premium Fleet with INEOS Grenadier

    A strikingly distinctive premium 4X4 now available to rent in the U.S. Hertz, one of the world's largest rental car companies, today announced the addition of the INEOS Grenadier to its U.S. rental fleet, further expanding the lineup of premium vehicles available to customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260318478091/en/Hertz expands premium fleet with INEOS Grenadier Hertz will provide customers with unmatched access to this premium 4X4 from INEOS Automotive – offering the largest availability of Grenadiers for rent anywhere in the U.S. Customers can reserve this coveted vehicle at select airport locations

    3/18/26 8:30:00 AM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    $AME
    $HTZ
    $MNMD
    $MOD
    Financials

    Live finance-specific insights

    View All

    AMETEK Increases Quarterly Dividend

    BERWYN, Pa., Feb. 12, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced its Board of Directors has approved a 10% increase in its quarterly cash dividend on common stock to $0.34 per share from $0.31 per share. The first quarter dividend is payable March 31, 2026 to shareholders of record as of March 16, 2026. This dividend increase will raise the indicated annual rate to $1.36 per share. "AMETEK continues to perform exceptionally well, delivering strong growth, outstanding cash flow generation and excellent operating results," stated David A. Zapico, Chairman and Chief Executive Officer. "AMETEK remains committed to deploying our robust cash flows on strategic acquisitions to en

    2/12/26 8:30:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    Modine Reports Third Quarter Fiscal 2026 Results

    Ongoing execution of planned production ramp for Data Center products drives top-line growth of 51% in Climate Solutions segment; raising full-year outlook for revenue and earnings RACINE, Wis., Feb. 4, 2026 /PRNewswire/ -- Modine (NYSE:MOD), a diversified global leader in thermal management technology and solutions, today reported financial results for the quarter ended December 31, 2025. Third Quarter Highlights: Net sales of $805.0 million increased $188.2 million, or 31 percent, from the prior yearSuccessfully terminated the U.S. pension plan, resulting in a $116.1 million

    2/4/26 4:15:00 PM ET
    $MOD
    Auto Parts:O.E.M.
    Consumer Discretionary

    DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.

    TORONTO and PARK CITY, Utah, Feb. 3, 2026 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, today announces the sale of LKC Technologies to AMETEK, Inc. (NYSE:AME). As leaders in the world of visual electrophysiology, LKC Technologies, a portfolio company of DW Healthcare Partners' Founders Fund, is dedicated to preserving sight by expanding access to objective functional retinal assessments. For over 35 years, LKC has pioneered innovations in diagnostic technology, transforming complex visual electrophysiology into intuitive, accessibl

    2/3/26 8:00:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HTZ
    $MNMD
    $MOD
    Leadership Updates

    Live Leadership Updates

    View All

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Lambda Appoints Heather Planishek as Chief Financial Officer

    Industry veteran brings deep financial and operational expertise as Lambda accelerates the deployment of AI factories to meet demand from hyperscalers, enterprises, and frontier labs building superintelligence Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek as Chief Financial Officer. Planishek brings deep experience scaling high-growth technology companies and will lead Lambda's global finance organization as the company continues to expand its infrastructure footprint and operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251208888678/en/Lambda appoints Heather Planishek as Chi

    12/8/25 8:00:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    AMETEK Appoints Robert J. Amodei Senior Vice President, Controller and Scott M. DelOrefice, Vice President, Group Controller

    Tom Montgomery to Retire Following 42 Years of Service BERWYN, Pa., Nov. 7, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of Robert J. Amodei as Senior Vice President, Controller effective January 1, 2026. Mr. Amodei currently serves as Vice President, Assistant Controller. He will replace Thomas M. Montgomery who has announced his retirement after 42 years of distinguished service with AMETEK. Mr. Montgomery will remain with the company as a Senior Advisor through 2026. AMETEK also announced the appointment of Scott M. DelOrefice as Vice President, Group Controller, Electromechanical Group effective January 1, 2026. Mr. DelOrefice currently serves as Divisiona

    11/7/25 8:00:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HTZ
    $MNMD
    $MOD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Palantir Technologies Inc.

    SC 13G/A - Palantir Technologies Inc. (0001321655) (Subject)

    11/14/24 5:47:09 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Mind Medicine (MindMed) Inc.

    SC 13G/A - Mind Medicine (MindMed) Inc. (0001813814) (Subject)

    11/14/24 4:05:16 PM ET
    $MNMD
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Modine Manufacturing Company

    SC 13G/A - MODINE MANUFACTURING CO (0000067347) (Subject)

    11/12/24 3:58:12 PM ET
    $MOD
    Auto Parts:O.E.M.
    Consumer Discretionary